Imageable biopsy site marker
AssigneeSenoRx, Inc.
InventorsFred Burbank, Paul Lubock, Michael Jones, Nancy Forcier
Life of this patent
Estimating the term…
Loading patent…
AssigneeSenoRx, Inc.
InventorsFred Burbank, Paul Lubock, Michael Jones, Nancy Forcier
Estimating the term…
A biopsy site marker having at least one small marker body or pellet of bioresorbable material such as gelatin, collagen, polylactic acid, polyglycolic acid which has a radiopaque object, preferably with a non-biological configuration. The at least one bioresorbable body or pellet with a radiopaque object is deposited into the biopsy site, by an delivery device that includes an elongated tubular body with a piston slidable within the tubular body. One end of the tube is placed into the biopsy site. At least one but preferably several marker bodies or pellets are deposited sequentially into the biopsy site through the tube. At least the bioresorbable materials of the detectable markers remain present in sufficient quantity to permit detection and location of the biopsy site at a first time point (e.g., 2 weeks) after introduction but clear from the biopsy site or otherwise do not interfere with imaging of tissues adjacent the biopsy site at a second time point (e.g., 5-7 months) after introduction.
A target tissue localization device comprising:
2-57. (canceled)
A target tissue localization device comprising:
The target tissue localization device of claim 5, wherein the bioresorbable body swells to substantially fill the biopsy site.
A method for marking a biopsy cavity comprising the steps of:
A target tissue localization device comprising:
A method for marking a biopsy cavity comprising the steps of:
A target tissue localization device comprising:
A method for marking a biopsy cavity comprising the steps of:
An intracorporeal site marker for marking a selected site within tissue of a patient's body, comprising:
A remotely imageable marker for marking a selected intracorporeal site within a patient, comprising:
A method of marking a selected intracorporeal tissue site for subsequent location, comprising:
Dependencies are inferred from the claim text.